1. P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: McCloskey, J.; Pullarkat, V.; Mannis, G.; Lin, T. L.; Strickland, S. A.; Fathi, A. T.; Erba, H. P.; Faderl, S.; Chakravarthy, D.; Lutska, Y.; Chandrasekaran, V.; Cheung, R. S.; Levis, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY. (23rd June 2022) Authors: Uy, G. L.; Pullarkat, V. A.; Baratam, P.; Stuart, R. K.; Walter, R. B.; Winer, E. S.; Faderl, S.; Chandrasekaran, V.; Wang, Q.; Chakravarthy, D.; Cheung, R. S.; Lin, T. L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗